GE HealthCare Technologies
GE HealthCare Technologies/ US36266G1076 /
GEHC
|
2024-04-29 9:59:58 PM
|
Chg.
+2.78
|
Volume |
Bid- |
Ask- |
High |
Low |
|
88.97USD
|
+3.23%
|
161,728
Turnover: 14.26 mill. |
-Bid Size: - |
-Ask Size: - |
89.16 |
86.38 |
Business description
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients.
Management board & Supervisory board
| CEO |
| Peter J. Arduini |
| Management board |
| James (Jay) Saccaro, Betty Larson, Frank Jimenez, Jan Makela, Kevin O Neill, Thomas Westrick, Elie Chaillot, Catherine Estrampes, Rob Walton, Yihao Zhang, Ken Stacherski, Laila Gurney, Jahid Khandaker, Dr. Taha Kass-Hout, Brian Montgomery, Danielle Halstrom, Carolynne Borders, Abigail Epane-Osuala, Mike Donohoe, Roland Rott |
| Supervisory board |
| Peter J. Arduini, H. Lawrence Culp, Jr., Dr. Rodney F. Hochman, Lloyd W. Howell, Jr., Dr. Risa Lavizzo-Mourey, Catherine Lesjak, Anne T. Madden, Dr. Tomislav Mihaljevic, William J. Stromberg, Phoebe L. Yang |
Company data
| Name: |
GE HealthCare Technologies Inc. |
| Address: |
500 West Monroe Street,Chicago, IL 60661 |
| Phone: |
+1-617-443-3400 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.gehealthcare.com |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
- |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
2023-01-04 |
Company calendar
|
CW 18 | 2024-04-30
Interim Report 1st Quarter/3 Months
|
|
CW 20 | 2024-05-15
Dividend Payment
|
